PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
4.34%
Net income growth under 50% of META's 10.17%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-6.51%
Negative yoy D&A while META is 11.33%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-690.72%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
5.62%
Less SBC growth vs. META's 16.57%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-306.35%
Both reduce yoy usage, with META at -271.20%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-242.85%
Both yoy AR lines negative, with META at -147.72%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-21.12%
Negative yoy inventory while META is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-8.88%
Negative yoy AP while META is 144.49%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-4535.85%
Negative yoy usage while META is 93.48%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
88.37%
Well above META's 175.76%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-28.47%
Negative yoy CFO while META is 6.39%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
46.93%
Some CapEx rise while META is negative at -27.80%. John Neff would see competitor possibly building capacity while we hold back expansions.
-45.80%
Negative yoy acquisition while META stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-2.60%
Both yoy lines negative, with META at -95.19%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
4.23%
Below 50% of META's 198.35%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
48.16%
We have mild expansions while META is negative at -29.73%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.